Moringa Arava Global

Company Overview

Snapshot

Founded in July 2006 by Micha Moran, Moringa Arava Global operates with 1–10 employees. The company focuses on developing pharmaceutical and nutritional products.

Business overview

Moringa Arava Global specializes in the development of pharmaceutical and nutritional products derived from the Moringa oleifera plant. Its core technology leverages the plant's properties for antiviral, antibacterial, and anti-allergenic uses, aiming to strengthen the immune system. The company's products, which include "Naturals by Phyllis" and "Moringa SuperFood Capsules," are designed to address a range of conditions such as rheumatoid arthritis, lupus, gout, type 2 diabetes, high cholesterol, hypothyroidism, and asthma. Serving both B2B2C and B2C models, Moringa Arava Global operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, with a focus on herbal medicine and supplements for consumers and pharmaceutical markets.

Company Intelligence Q&A

What is Moringa Arava Global's primary focus?

Moringa Arava Global develops pharmaceutical and nutritional products based on the Moringa oleifera plant, targeting antiviral, antibacterial, and anti-allergenic uses to strengthen the immune system.

What types of conditions do Moringa Arava Global's products address?

The company's products are used to treat a wide range of conditions, including rheumatoid arthritis, lupus, gout, type 2 diabetes, high cholesterol, hypothyroidism, and asthma.

Are Moringa Arava Global's products approved by regulatory bodies?

All of Moringa Arava Global's products are approved by the FDA and the Israeli Ministry of Health.

Who founded Moringa Arava Global?

Moringa Arava Global was founded by Micha Moran in July 2006.

What are some of the key ingredients in Moringa Arava Global's products?

The company's products contain high amounts of vitamin E and calcium, with moringa seeds particularly recommended for the treatment of asthma and atopic dermatitis.